Gba3 - glucosylceramidase beta 3 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 289687
Summary
Predicted to enable hydrolase activity, hydrolyzing O-glycosyl compounds. Predicted to be involved in several processes, including cellular oligosaccharide catabolic process; glycosylceramide catabolic process; and positive regulation of exo-alpha-sialidase activity. Predicted to be part of catalytic complex. Predicted to be active in cytosol. Orthologous to human GBA3 (glucosylceramidase beta 3 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2022]
Gba3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001395627.1 | NP_001382556.1 | glucosylceramidase beta 3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
glucosylceramidase beta 3 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS05303 | GBA3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27250 | Gba3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service